Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A phase II study of continuous dosing sunitinib in patients with non-GIST soft tissue sarcoma: early results [abstract]

A phase II study of continuous dosing sunitinib in patients with non-GIST soft tissue sarcoma: early results [abstract]. Connective Tissue Oncology Society. 2007; 881.


© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.